#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA5108575	B	Competitive inhibition of biotinylated heparin binding to His-tagged wild type SARS-COV-2 spike protein at 50 uM incubated for 300 sec by biolayer interferometry streptavidin sensor based assay	Severe acute respiratory syndrome coronavirus 2	6		single protein format	Scientific Literature
2.	ALA5108576	B	Competitive inhibition of biotinylated heparin binding to His-tagged wild type SARS-COV-2 spike protein incubated for 300 sec by biolayer interferometry streptavidin sensor based assay	Severe acute respiratory syndrome coronavirus 2	1		single protein format	Scientific Literature
3.	ALA5108577	B	Competitive inhibition of biotinylated heparin binding to His-tagged wild type SARS-COV-2 spike protein assessed inhibition constant incubated for 300 sec by biolayer interferometry streptavidin sensor based assay	Severe acute respiratory syndrome coronavirus 2	1		single protein format	Scientific Literature
4.	ALA5108578	B	Competitive inhibition of biotinylated heparin binding to His-tagged SARS-COV-2 B.1.1.7 variant recombinant spike glycoprotein del69-70/del144/N501Y/A570D/D614G/P681H/T716I/S982A/D1118H mutant expressed in Expi293F cells incubated for 120 sec by biolayer interferometry streptavidin sensor based assay	Severe acute respiratory syndrome coronavirus 2	1		cell-based format	Scientific Literature
5.	ALA5108579	B	Competitive inhibition of biotinylated heparin binding to His-tagged SARS-COV-2 B.1.351 variant recombinant spike glycoprotein D80A/D215G/K417N/E484K/N501Y/D614G/A701V mutant expressed in Expi293F cells incubated for 120 sec by biolayer interferometry streptavidin sensor based assay	Severe acute respiratory syndrome coronavirus 2	1		cell-based format	Scientific Literature
6.	ALA5108580	B	Competitive inhibition of biotinylated heparin binding to His-tagged SARS-COV-2 P.1 variant recombinant spike glycoprotein L18F/T20N/P26S/D138Y/R190S/K417T/E484K/N501Y/H655Y/T1027I mutant expressed in Expi293F cells incubated for 300 sec by biolayer interferometry streptavidin sensor based assay	Severe acute respiratory syndrome coronavirus 2	1		cell-based format	Scientific Literature
7.	ALA5108581	B	Competitive inhibition of biotinylated heparin binding to His-tagged SARS-COV-2 B.1.1.7 variant recombinant spike glycoprotein del69-70/del144/N501Y/A570D/D614G/P681H/T716I/S982A/D1118H mutant expressed in Expi293F cells assessed as inhibition constant incubated for 120 sec by biolayer interferometry streptavidin sensor based assay	Severe acute respiratory syndrome coronavirus 2	1		cell-based format	Scientific Literature
8.	ALA5108582	B	Competitive inhibition of biotinylated heparin binding to His-tagged SARS-COV-2 B.1.351 variant recombinant spike glycoprotein D80A/D215G/K417N/E484K/N501Y/D614G/A701V mutant expressed in Expi293F cells assessed as inhibition constant incubated for 120 sec by biolayer interferometry streptavidin sensor based assay	Severe acute respiratory syndrome coronavirus 2	1		cell-based format	Scientific Literature
9.	ALA5108583	B	Competitive inhibition of biotinylated heparin binding to His-tagged SARS-COV-2 P.1 variant recombinant spike glycoprotein L18F/T20N/P26S/D138Y/R190S/K417T/E484K/N501Y/H655Y/T1027I mutant expressed in Expi293F cells assessed as inhibition constant incubated for 300 sec by biolayer interferometry streptavidin sensor based assay	Severe acute respiratory syndrome coronavirus 2	1		cell-based format	Scientific Literature
10.	ALA5108585	B	Inhibition of coagulation factor Xa (unknown origin) using FXa specific chromogenic substrate at 10 ug/ml preincubated for 2 mins in presence of antithrombin III followed by factor Xa addition for 2 mins and chromogenic substrate and measured after 2 mins by spectrophotometer based microplate reader method	Homo sapiens	1		single protein format	Scientific Literature